About
EndoQuest Robotics is a pioneering medical robotics company redefining minimally invasive surgery through its next-generation Endoluminal Robotic Surgical System (ELSS). The platform represents the world's first flexible robotic system purpose-built for endoluminal and single-incision surgical procedures. Unlike conventional open, laparoscopic, or robotic surgery — which require incisions through healthy tissue to reach the operative site — EndoQuest's approach routes surgical instruments through the body's natural orifices (mouth and anus) or a transumbilical incision. This eliminates or dramatically minimizes external incisions, leading to significantly reduced scarring, lower patient trauma, and faster recovery. The system is engineered to extend physician capabilities, providing surgeons with precise robotic control in anatomical regions previously inaccessible to standard robotic platforms. Key supported approaches include transoral, transanal, and transumbilical procedures, with primary applications in gastrointestinal and colorectal surgery. EndoQuest's clinical goals include enhancing surgical outcomes, shortening hospital stays, and reducing the overall cost burden of complex GI procedures. The system is currently under development and has not yet received FDA clearance for commercial use in the United States, but represents a significant breakthrough in next-generation flexible surgical robotics for healthcare institutions and surgical specialists worldwide.
Key Features
- Flexible Robotic Platform: The world's first flexible robotic surgery system capable of navigating the body's natural anatomy to perform endoluminal procedures with robotic precision.
- Endoluminal & Single-Incision Surgery: Enables surgery through the mouth, anus, or a single transumbilical incision, eliminating the need for multiple external cuts through healthy tissue.
- Multi-Approach Capability: Supports transoral, transanal, and transumbilical surgical approaches to address a wide range of gastrointestinal and colorectal procedures.
- Enhanced Physician Control: Provides surgeons with precise robotic assistance in anatomical spaces previously inaccessible to conventional robotic platforms.
- Reduced Patient Trauma & Recovery: Designed to minimize scarring, post-operative pain, and recovery time compared to open or laparoscopic surgical alternatives.
Use Cases
- Minimally invasive colorectal surgery performed through transanal access without external abdominal incisions
- Transoral gastrointestinal procedures for upper GI conditions that previously required open or laparoscopic surgery
- Single-incision transumbilical abdominal surgery reducing post-operative scarring and patient recovery time
- Robotic-assisted endoscopic resection of gastrointestinal tumors or lesions with enhanced precision
- Clinical research and trials exploring next-generation flexible robotic surgical techniques at academic medical centers
Pros
- Truly Minimally Invasive: Eliminates or significantly reduces external incisions, resulting in less scarring, reduced trauma, and improved cosmetic outcomes for patients.
- Faster Patient Recovery: Less tissue disruption translates to shorter hospital stays and quicker return to normal activities, reducing overall healthcare costs.
- Pioneering First-of-Its-Kind Technology: Opens entirely new surgical frontiers with a flexible robotic system that makes previously inaccessible anatomical regions operable with robotic precision.
Cons
- Not Yet FDA Cleared: The Endoluminal Robotic Surgical System is still under development and has not received FDA clearance, limiting its availability for commercial clinical use in the United States.
- Limited Availability: As a next-generation platform still in development, widespread hospital and clinical access is not yet possible, restricting use to research and trial settings.
Frequently Asked Questions
EndoQuest Robotics is a medical robotics company developing the world's first flexible robotic surgical system designed for endoluminal and single-incision procedures, enabling surgery with minimal or no external incisions.
Endoluminal surgery is a minimally invasive approach that accesses the surgical site through the body's natural orifices — such as the mouth or anus — without requiring external incisions through healthy tissue, reducing trauma and recovery time.
No. The Endoluminal Robotic Surgical System is currently under development and has not been cleared by the FDA. It is not yet available for commercial sale in the United States.
The system supports transoral, transanal, and transumbilical surgical approaches, with primary applications in gastrointestinal and colorectal surgery procedures.
Unlike conventional robotic surgery systems that require multiple incisions through healthy tissue to reach the surgical site, EndoQuest's flexible platform works through natural body orifices or a single small incision, dramatically reducing trauma, scarring, and recovery time.